Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06450912 · ClinicalTrials.gov registry record
Novel Imaging Biomarkers for Mechanical Complications in Acute Myocardial Infarction
A clinical trial, sponsored by Rohan Dharmakumar.
- Completed
- Registry status
- 250
- Enrollment target
NCT06450912: Completed study, sponsored by Rohan Dharmakumar.
NCT06450912 is a clinical trial that has completed, run by Rohan Dharmakumar. The registered enrollment target is 250 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06450912 has completed, sponsored by Rohan Dharmakumar.
- COMPLETED
- Registry status
- 250 participants
- Enrollment target
Study Summary
Hemorrhagic Myocardial infarctions are at high risk for mechanical complications including cardiac rupture. Prediction of vulnerable myocardial segments is an important step for the stratification of hemorrhagic MI patients. Wall motion index ratio is an important parameter to determine regions of high vulnerability within the 17-segment LV model of hemorrhagic MI.
Primary Outcome
Difference in Wall Strain Index values between patients with intramyocardial hemorrhage and those without, confirmed by cardiac MRI.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2022-06-01 |
| Est. Completion | 2024-06-01 |
What the finished NCT06450912 record still lists
NCT06450912 is an observational study that tracks outcomes without assigning an intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT06450912 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06450912 about?
NCT06450912 is a clinical study titled "Novel Imaging Biomarkers for Mechanical Complications in Acute Myocardial Infarction". Hemorrhagic Myocardial infarctions are at high risk for mechanical complications including cardiac rupture. Prediction of vulnerable myocardial segments is an important step for the stratification of hemorrhagic MI patients. Wall motion index ratio is an important parameter to determine regions of h...
What is the current status of trial NCT06450912?
This trial is currently completed. The enrollment target is 250 participants. The study started on 2022-06-01. Estimated completion is 2024-06-01.
Who is sponsoring clinical trial NCT06450912?
This trial is sponsored by Rohan Dharmakumar, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI